Cue Biopharma shares owned by UBS Group
Historical chart of UBS Group investment in Cue Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Cue Biopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Cue Biopharma by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $262k | 99k | 2.64 |
2023-09-30 | $182k | 79k | 2.30 |
2023-06-30 | $293k | 80k | 3.65 |
2023-03-31 | $207k | 58k | 3.57 |
2022-12-31 | $69k | 24k | 2.85 |
2022-09-30 | $54k | 24k | 2.24 |
2022-06-30 | $73k | 28k | 2.57 |
2022-03-31 | $133k | 26k | 5.19 |
2021-12-31 | $1.2M | 109k | 11.30 |
2021-09-30 | $855k | 59k | 14.59 |
2021-06-30 | $314k | 27k | 11.62 |
2021-03-31 | $640k | 52k | 12.20 |
2020-12-31 | $288k | 23k | 12.77 |
2020-09-30 | $325k | 22k | 15.05 |
2020-06-30 | $529k | 22k | 24.50 |
2020-03-31 | $439k | 31k | 14.18 |
2019-12-31 | $933k | 59k | 15.86 |
2019-09-30 | $409k | 49k | 8.42 |
2019-06-30 | $326k | 36k | 8.99 |
2019-03-31 | $274k | 30k | 9.01 |
2018-12-31 | $175k | 37k | 4.69 |
2018-09-30 | $235k | 26k | 9.00 |
2018-06-30 | $279k | 23k | 12.06 |
2018-03-31 | $53k | 3.7k | 14.23 |